1990
DOI: 10.1016/s0021-9258(19)38551-5
|View full text |Cite
|
Sign up to set email alerts
|

Mapping the alpha-subunit site photolabeled by the noncompetitive inhibitor [3H]quinacrine azide in the active state of the nicotinic acetylcholine receptor.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
20
0

Year Published

1992
1992
2006
2006

Publication Types

Select...
7
1
1

Relationship

0
9

Authors

Journals

citations
Cited by 92 publications
(20 citation statements)
references
References 74 publications
0
20
0
Order By: Relevance
“…Most noncompetitive inhibitors exert little action unless the ion channel has been opened by an agonist (Adams, 1976;Changeux, 1990;Neely & Lingle, 1986;Neher & Steinbach, 1978;Ogden et al, 1981). Time-resolved photolabeling offered further evidence for the open state inhibition model with photoactive [3H]chlorpromazine and [3H]quinacrine azide as the inhibitor (Heidmann & Changeux, 1984; Heidmann & Changeux, 1986;DiPaola et al, 1990).…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…Most noncompetitive inhibitors exert little action unless the ion channel has been opened by an agonist (Adams, 1976;Changeux, 1990;Neely & Lingle, 1986;Neher & Steinbach, 1978;Ogden et al, 1981). Time-resolved photolabeling offered further evidence for the open state inhibition model with photoactive [3H]chlorpromazine and [3H]quinacrine azide as the inhibitor (Heidmann & Changeux, 1984; Heidmann & Changeux, 1986;DiPaola et al, 1990).…”
Section: Discussionmentioning
confidence: 99%
“…Under equilibrium conditions, noncompetitive inhibitors can label the nAcChoR in the resting state (in the absence of agonist) and the desensitized state (sustained application of agonist), but rapid labeling techniques must be used to label the transient open state before desensitization (Cox et al, 1984; Heidmann & Changeux, 1984;Muhn et al, 1984). Though the results obtained from these rapid labeling experiments were controversial because of the complication of receptor desensitization (Cox et al, 1985; Heidmann & Changeux, 1984Changeux, , 1986, there is strong evidence that the transient open state is labeled by [3 *H]chlorpromazine and [3H]quinacrine azide (DiPaola et al, 1990; Heidmann & Changeux, 1986). To date, photolabeling with [125I]TID has only been done under equilibrium conditions.…”
mentioning
confidence: 99%
“…Not all evidence, however, points to the region between ␣ S248 and ␣ S252 as the sole binding site in the channel. Quinacrine azide photolabeled residues at the extracellular end of ␣ M1, specifically in the open state of the channel (Karlin, 1989;DiPaola et al, 1990), and mutations at the extracellular end of ␣ M1 affected quinacrine but not chlorpromazine binding (Tamamizu et al, 1995). Nevertheless, chlorpromazine and a number of other NCIs retarded the labeling by quina-crine azide (DiPaola et al, 1990) and competed with the binding of quinacrine (Lurtz et al, 1997).…”
Section: Introductionmentioning
confidence: 99%
“…(a) The noncompetitive antagonists [3H]chlorpromazine and [aH]triphenylmethylphosphonium photolabel residues in M2 (Giraudat, Dennis, Heidmann, Chang, and Changeux, 1986;Hucho, Oberthiir, and Lottspeich, 1986;Oberthtir, Muhn, Baumann, Lottspeich, Wittman-Liebold, and Hucho, 1986;Giraudat, Dennis, Heidmann, Haumont, Lederer, and Changeux, 1987;Giraudat, Galzi, Revah, Changeux, Haumont, and Lederer, 1989;Revah, Galzi, Giraudat, Haumont, Lederer, and Changeux, 1990); (b) mutations in M2 affect single-channel conductance and ion selectivity (Imoto, Methfessel, Sakmann, Mishina, Mori, Konno, Fukuda, Kurasaki, Bujo, Fujita, and Numa, 1986;Imoto, Busch, Sakmann, Mishina, Konno, Nakai, Bujo, Mori, Fukuda, and Numa, 1988;Leonard, Labarca, Charnet, Davidson, and Lester, 1988;Charnet, Labarca, Leonard, Vogelaar, Czyzyk, Gouin, Davidson, and Lester, 1990;Imoto, Konno, Nakai, Wang, Mishina, and Numa, 1991;Konno, Busch, von Kitzing, Imoto, Wang, Nakai, Mishina, Numa, and Sakmann, 1991;Villarroel, Herlitze, Koenen, and Sakmann, 1991;Cohen, Labarca, Czyzyk, Davidson, and Lester, 1992); and (c) mutations in M2 affect block of the nAChR by QX-222 (Leonard et al, 1988;Charnet et al, 1990). M1 may also form part of the pore lining (DiPaola, Kao, and Karlin, 1990).…”
Section: Introductionmentioning
confidence: 99%